- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-33-0137621

Well Life Pharmaceuticals Private Limited
About Well Life Pharmaceuticals Private Limited
Data last updated:
Well Life Pharmaceuticals Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 08 June 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24239MH2010PTC203805. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Jugal Prafulchandra Shah and Dhiraj Shivnandan Gupta.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Thane, Maharashtra.
As per the financials filed for FY 2024, the company reported a revenue of ₹4.33 Cr, a decline of 7% compared to the previous year. For the same year it recorded a net profit of ₹4.01 Lakh (net margin 0.9%) and EBITDA of ₹13.18 Lakh (EBITDA margin 3%). Revenue has grown at a compounded annual rate (CAGR) of 1% over three years and 21% over five years.
As per MCA filings, the company has open charges of ₹96.68 Lakh and satisfied charges of ₹30 Lakh on record.
Well Life Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-33-0137621). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Recognitions & Rankings of Well Life Pharmaceuticals
Contact details
Well Life Pharmaceuticals Private Limited's registered office is in Thane, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressGala No.3 Sec – 13 Shanti Est Agarwal Est.Sec – 13 Hissa No.2 Bhnd Safari Hotel Kashigaon M, Ira Road – E, Thane, Maharashtra, India – 401107
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Well Life Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Well Life Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale and retail trade and repair of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 45 | Wholesale and retail trade and repair of motor vehicles and motorcycles |
To see the full business activity and turnover split of Well Life Pharmaceuticals Private Limited, buy the company report.
Financials of Well Life Pharmaceuticals Private Limited
FY 2025 filings availableWell Life Pharmaceuticals Private Limited reported revenue of ₹4.33 Cr (down 7% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 7% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 21%. EBITDA fell 22% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹13.18 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹4.01 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3% | ||||
| Net Profit Margin | 0.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Well Life Pharmaceuticals Private Limited, buy the company report.
Board of directors of Well Life Pharmaceuticals Private Limited
Well Life Pharmaceuticals has 5 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jugal Prafulchandra Shah | Director | 12 Nov 2019 | 7 Years 0 Months | Current |
| Dhiraj Shivnandan Gupta Also directs: Nandan Pharma Private Limited | Director | 30 Mar 2024 | 2 Years 7 Months | Current |
| Bhavini Savla Jay | Director | 29 May 2015 | 11 Years 5 Months | Current |
| Anshu Gupta | Director | 08 Jun 2010 | 16 Years 5 Months | Current |
| Jay Girish Savla | Director | 29 May 2015 | 11 Years 5 Months | Current |
Auditor
Well Life Pharmaceuticals Private Limited is audited by S D G & CO for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S D G & CO | FY 2020 | 137864W |
Shareholding
The shareholding of Well Life Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Well Life Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 23 Oct 2024 | 101040992 | Others | ₹90 Lakh | Open | |
| 13 Aug 2024 | 100994483 | Others | ₹6.68 Lakh | Open | |
| 20 May 2015 | 10586039 | The Cosmos Co-Op Bank Ltd | ₹30 Lakh | Satisfied |
To see the full charge records of Well Life Pharmaceuticals Private Limited, buy the company report.
Total charge records: 3 View all charges
Legal cases
No court or tribunal cases involving Well Life Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Well Life Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Well Life Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Well Life Pharmaceuticals Private Limited, buy the company report.
Recent activity
Well Life Pharmaceuticals Private Limited has 10 board changes on record since 2010: 5 appointments and 5 cessations. The latest: Dhiraj Shivnandan Gupta ceased to be Additional Director on 29 Sep 2024.
5 earlier events are in the company report.
Frequently asked questions
Well Life Pharmaceuticals is an active private limited company based in Thane, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 08 June 2010 (16+ years old) and is registered under CIN U24239MH2010PTC203805.
Well Life Pharmaceuticals has 5 current directors:
- Jugal Prafulchandra Shah - Director
- Dhiraj Shivnandan Gupta - Director
- Bhavini Savla Jay - Director
- Anshu Gupta - Director
- Jay Girish Savla - Director
The latest financial statements of Well Life Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
No. Well Life Pharmaceuticals has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Well Life Pharmaceuticals is U24239MH2010PTC203805. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Well Life Pharmaceuticals was incorporated on 08 June 2010, making it 16+ years old. It is registered with the Registrar of Companies, Mumbai.
Dhiraj Shivnandan Gupta ceased to be Additional Director on 29 Sep 2024. Dhiraj Shivnandan Gupta was appointed as Director on 30 Mar 2024. Deepak Parmabhai Patel ceased to be Director on 09 Mar 2024. Well Life Pharmaceuticals has 10 board changes on record in total.
Yes, Well Life Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-33-0137621).
The registered office of Well Life Pharmaceuticals is at Gala No.3 Sec – 13 Shanti Est Agarwal Est.Sec – 13 Hissa No.2 Bhnd Safari Hotel Kashigaon M, Ira Road – E, Thane, Maharashtra, India – 401107.
Well Life Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

